Skip to main content
A

Abnova (Taiwan) Corporation — Investor Relations & Filings

Ticker · 4133 TW Professional, scientific and technical activities
Open in API
Filings indexed 1,472 across all filing types
Latest filing 2026-04-27 AGM Information
Country TW Taiwan
Listing TW 4133

About Abnova (Taiwan) Corporation

http://www.abnova.com

Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.

Recent filings

Filing Released Lang Actions
115年年報及股東會資料 — 2026_4133_20260529F02.pdf
AGM Information Classification · 1% confidence The document is titled “115年股東常會議事手冊” (Annual General Meeting handbook) and contains the full AGM agenda, resolutions, board reports, attachments including the annual business report, auditor reports, financial statements, director election materials, bylaws, etc. It is clearly the substantive materials provided for the Annual General Meeting rather than a mere notice or summary. This matches the definition of AGM Information (Code: AGM-R).
2026-04-27 Chinese
115年年報及股東會資料 — 2026_4133_20260529F13.pdf
AGM Information Classification · 1% confidence The document is the full set of reference materials and agenda items for the company’s 115th Annual General Meeting (股東常會), including the meeting notice, proposals, reports, election details, and voting items. It is not a standalone financial report or earnings release but the materials prepared for and shared at the AGM. Therefore it should be classified as AGM Information (AGM-R).
2026-04-27 Chinese
115年年報及股東會資料 — 2026_4133_20260529FE2.pdf
Regulatory Filings
2026-04-27 Chinese
115年年報及股東會資料 — 2026_4133_20260529FE1.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a short notice of the upcoming General Shareholders’ Meeting, including the meeting agenda and matters to be voted on. It is sent to shareholders to inform them of the meeting and solicit their votes (e.g., ratification, election of directors). This corresponds to the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-27 English
115年年報及股東會資料 — 2026_4133_20260529F01.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder meeting notice for the company’s 115th Annual General Meeting, containing proxy forms, voting instructions, list of solicitors, meeting agenda and related materials. It is soliciting proxies and providing information to shareholders to request votes, rather than presenting financial statements or reporting results. This matches the Proxy Solicitation & Information Statement category (PSI).
2026-04-27 Chinese
115年3月背書保證與資金貸與
Regulatory Filings Classification · 1% confidence The document is a regulatory disclosure from the Taiwan Public Information Observatory (“公開資訊觀測站”) showing intercompany loan and guarantee balances for company “亞諾法”. It is not an annual report, earnings release, AGM material, or any management presentation. Rather, it is a routine regulatory filing disclosing funding loans and guarantee information. This falls under the fallback category ‘Regulatory Filings’ (RNS).
2026-04-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.